• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempest Therapeutics, Inc. - Common Stock (NQ:TPST)

1.110 +0.010 (+0.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempest Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Glancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST)
May 31, 2024
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Tempest to Participate in Upcoming Investor Conferences
May 21, 2024
From Tempest Therapeutics
Via GlobeNewswire
News headline image
TPST Stock Earnings: Tempest Therapeutics Beats EPS for Q1 2024 ↗
May 09, 2024
TPST stock results show that Tempest Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From Tempest Therapeutics
Via GlobeNewswire
“Market Mavericks: Stocks Creating Ripples of Success” CLNV, TPST, HNRC, INPX
November 15, 2023
Via AB Newswire
News headline image
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 26, 2024
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting
April 09, 2024
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
April 05, 2024
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition. 
Via Benzinga
News headline image
Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications
April 04, 2024
From Tempest Therapeutics
Via GlobeNewswire
News headline image
TPST Stock Earnings: Tempest Therapeutics Beats EPS for Q4 2023 ↗
March 19, 2024
TPST stock results show that Tempest Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Tempest Reports Year End 2023 Financial Results and Provides Business Update
March 19, 2024
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Glancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST)
March 14, 2024
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types
March 12, 2024
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting
March 05, 2024
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest to Present at the 44th Annual TD Cowen Healthcare Conference
February 26, 2024
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2024
From Tempest Therapeutics
Via GlobeNewswire
Tempest Therapeutics Announces Groundbreaking Advances in Liver Cancer Treatment, Showcasing Exceptional Efficacy and Safety Data at ASCO Annual Meeting 2024
January 30, 2024
Via AB Newswire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
January 16, 2024
 
Via Benzinga
News headline image
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 05, 2024
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2023
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference
November 20, 2023
From Tempest Therapeutics
Via GlobeNewswire
Intelligent Bio (NASDAQ: INBS) Surges Massively Among Stocks Making BUZZ:TPST, HNST, LTRN, VTAK
November 14, 2023
Via AB Newswire
News headline image
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
November 09, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
November 09, 2023
 
Via Benzinga
News headline image
Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings ↗
November 09, 2023
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53.... 
Via Benzinga
Topics Stocks
News headline image
Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update
November 08, 2023
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Biggest Short Squeeze Stocks Of The Week: Two Biotech Stocks Move Up To Top The List ↗
October 31, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of traders looking for the next huge move. High short interest and steep borrowing costs are among the... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
October 24, 2023
 
Via Benzinga
News headline image
MarketBeat Week in Review – 10/16 - 10/20
October 21, 2023
All the major indexes moved lower on Friday, making it a near certainty that stocks would post their worst week in a month; the bears are firmly in control 
Via MarketBeat
Topics Bonds Economy
News headline image
Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
October 18, 2023
Gainers Shift Technologies, Inc. (NASDAQ: SFT) shares climbed 107.8% to $0.2239. Shift Technologies recently said it will file for Chapter 11 bankruptcy protection. 
Via Benzinga
Topics Bankruptcy
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap